Interestingly, the axillary and pelvic LNs of the patient showed a significant increasing trend in k3, which is consistent with the expected global effect of anti–PD-1 immunotherapy on peripheral T cells, distant from the primary tumor. This evidence concerns the gene PDCD1 and neoplasm.